CN106866798A - J亚群禽白血病病毒特异性抗原表位、融合蛋白、特异性抗体及其应用 - Google Patents
J亚群禽白血病病毒特异性抗原表位、融合蛋白、特异性抗体及其应用 Download PDFInfo
- Publication number
- CN106866798A CN106866798A CN201710183771.2A CN201710183771A CN106866798A CN 106866798 A CN106866798 A CN 106866798A CN 201710183771 A CN201710183771 A CN 201710183771A CN 106866798 A CN106866798 A CN 106866798A
- Authority
- CN
- China
- Prior art keywords
- subgroup
- avian leucosis
- subgroup avian
- fusion protein
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000271566 Aves Species 0.000 title claims abstract description 46
- 241000700605 Viruses Species 0.000 title claims abstract description 36
- 239000000427 antigen Substances 0.000 title claims abstract description 31
- 108091007433 antigens Proteins 0.000 title claims abstract description 31
- 102000036639 antigens Human genes 0.000 title claims abstract description 31
- 108020001507 fusion proteins Proteins 0.000 title claims abstract description 20
- 102000037865 fusion proteins Human genes 0.000 title claims abstract description 20
- 238000001514 detection method Methods 0.000 claims abstract description 23
- 229960005486 vaccine Drugs 0.000 claims abstract description 7
- 230000003053 immunization Effects 0.000 claims abstract description 5
- 238000002649 immunization Methods 0.000 claims abstract description 5
- 241001465754 Metazoa Species 0.000 claims abstract description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 208000004668 avian leukosis Diseases 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 10
- 238000003259 recombinant expression Methods 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 239000013604 expression vector Substances 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 210000002966 serum Anatomy 0.000 abstract description 28
- 238000006243 chemical reaction Methods 0.000 abstract description 11
- 238000002474 experimental method Methods 0.000 abstract description 5
- 230000009385 viral infection Effects 0.000 abstract description 4
- 108091008034 costimulatory receptors Proteins 0.000 abstract description 3
- 208000031295 Animal disease Diseases 0.000 abstract description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 33
- 102000004196 processed proteins & peptides Human genes 0.000 description 31
- 229920001184 polypeptide Polymers 0.000 description 27
- 101800001271 Surface protein Proteins 0.000 description 12
- 241000287828 Gallus gallus Species 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 241000713826 Avian leukosis virus Species 0.000 description 10
- 238000002965 ELISA Methods 0.000 description 10
- 239000011248 coating agent Substances 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 241000323253 Avian leukosis virus ev/J Species 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241001428887 Avian leukosis virus - RSA Species 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000005570 vertical transmission Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000019838 Blood disease Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108091005703 transmembrane proteins Proteins 0.000 description 2
- 102000035160 transmembrane proteins Human genes 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 1
- TTXYKSADPSNOIF-IHRRRGAJSA-N Arg-Asp-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O TTXYKSADPSNOIF-IHRRRGAJSA-N 0.000 description 1
- OWSMKCJUBAPHED-JYJNAYRXSA-N Arg-Pro-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OWSMKCJUBAPHED-JYJNAYRXSA-N 0.000 description 1
- VENMDXUVHSKEIN-GUBZILKMSA-N Arg-Ser-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VENMDXUVHSKEIN-GUBZILKMSA-N 0.000 description 1
- GOVUDFOGXOONFT-VEVYYDQMSA-N Asn-Arg-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GOVUDFOGXOONFT-VEVYYDQMSA-N 0.000 description 1
- RAQMSGVCGSJKCL-FOHZUACHSA-N Asn-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(N)=O RAQMSGVCGSJKCL-FOHZUACHSA-N 0.000 description 1
- WSXDIZFNQYTUJB-SRVKXCTJSA-N Asp-His-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O WSXDIZFNQYTUJB-SRVKXCTJSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- FNXOZWPPOJRBRE-XGEHTFHBSA-N Cys-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CS)N)O FNXOZWPPOJRBRE-XGEHTFHBSA-N 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- RDDSZZJOKDVPAE-ACZMJKKPSA-N Glu-Asn-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDDSZZJOKDVPAE-ACZMJKKPSA-N 0.000 description 1
- MFVQGXGQRIXBPK-WDSKDSINSA-N Gly-Ala-Glu Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFVQGXGQRIXBPK-WDSKDSINSA-N 0.000 description 1
- JVACNFOPSUPDTK-QWRGUYRKSA-N Gly-Asn-Phe Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JVACNFOPSUPDTK-QWRGUYRKSA-N 0.000 description 1
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 1
- IIWQTXMUALXGOV-PCBIJLKTSA-N Ile-Phe-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N IIWQTXMUALXGOV-PCBIJLKTSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- GPJGFSFYBJGYRX-YUMQZZPRSA-N Lys-Gly-Asp Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O GPJGFSFYBJGYRX-YUMQZZPRSA-N 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- BIYWZVCPZIFGPY-QWRGUYRKSA-N Phe-Gly-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O BIYWZVCPZIFGPY-QWRGUYRKSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- NERYDXBVARJIQS-JYBASQMISA-N Ser-Trp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N)O NERYDXBVARJIQS-JYBASQMISA-N 0.000 description 1
- 101800000385 Transmembrane protein Proteins 0.000 description 1
- 101100393276 Trypanosoma cruzi GP85 gene Proteins 0.000 description 1
- GXAZTLJYINLMJL-LAEOZQHASA-N Val-Asn-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N GXAZTLJYINLMJL-LAEOZQHASA-N 0.000 description 1
- YLHLNFUXDBOAGX-DCAQKATOSA-N Val-Cys-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N YLHLNFUXDBOAGX-DCAQKATOSA-N 0.000 description 1
- CJDZKZFMAXGUOJ-IHRRRGAJSA-N Val-Cys-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N CJDZKZFMAXGUOJ-IHRRRGAJSA-N 0.000 description 1
- GBIUHAYJGWVNLN-AEJSXWLSSA-N Val-Ser-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N GBIUHAYJGWVNLN-AEJSXWLSSA-N 0.000 description 1
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical group [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108700004026 gag Genes Proteins 0.000 description 1
- 101150098622 gag gene Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000005571 horizontal transmission Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229940005654 nitrite ion Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 108090000623 proteins and genes Chemical group 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000020509 sex determination Effects 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
- C12N2740/11022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
- C12N2740/11034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
编号 | 序列 | 名称 | 长度 | 来源 |
1 | GYFFFQMILVCVVIISVVPGVGG | J-Pep1 | 23 | J |
2 | VNYILTIGVLVLCEVTGVRAD | A-Pep2 | 21 | A |
3 | NCTTLGTDRLVSSASITGGPDNSTT | A-Pep3 | 25 | A |
4 | DNSTTLTYRKVSCLLLKLNVSMWED | A-Pep4 | 25 | A |
5 | NGTNRTCVTFGSVCYEENSRSRVCHIFDGNFNGTG | J-Pep5 | 35 | J |
6 | GTGGAEAELRDFIEKWKGDDHLIRPYVNQSWTMVSPIN | J-Pep6 | 38 | J |
7 | PINTGSFSISS RYCGFTSNEARYYGGNLSDWCNSK | J-Pep7 | 35 | J |
8 | SNSTEPFTVVTADRHNLFTGSEYCGAYGYRFWE | A-Pep8 | 33 | A |
9 | VNQSREINETEPFSFTVNCTASNL | A-Pep9 | 22 | A |
10 | GGNCTAEWNYYAYGFTFGKQPEVLWNNGTA | J-Pep10 | 30 | J |
11 | SPNFTTWITYGPNITGHRRSR | J-Pep11 | 21 | J |
12 | APNHTDILKILANSSRTGIRRK | AB-Pep12 | 21 | AB |
13 | AIIPCIIKCFQDCLSRTMNQFMDDRIR | J-Pep13 | 27 | J |
14 | VCLPCLLQIVSRSVRKMVDN | A-Pep14 | 23 | A |
15 | NSIGYHTEYKKLQKACRQP | A-Pep15 | 19 | A |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710183771.2A CN106866798B (zh) | 2017-03-24 | 2017-03-24 | J亚群禽白血病病毒特异性抗原表位、融合蛋白、特异性抗体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710183771.2A CN106866798B (zh) | 2017-03-24 | 2017-03-24 | J亚群禽白血病病毒特异性抗原表位、融合蛋白、特异性抗体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106866798A true CN106866798A (zh) | 2017-06-20 |
CN106866798B CN106866798B (zh) | 2020-02-14 |
Family
ID=59172868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710183771.2A Active CN106866798B (zh) | 2017-03-24 | 2017-03-24 | J亚群禽白血病病毒特异性抗原表位、融合蛋白、特异性抗体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106866798B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107353324A (zh) * | 2017-07-05 | 2017-11-17 | 河南牧业经济学院 | 与禽白血病病毒p27蛋白相结合的多肽及其应用 |
CN114349829A (zh) * | 2022-01-14 | 2022-04-15 | 华南农业大学 | Alv-j mhc-b2限制性表位肽的鉴定及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106442982A (zh) * | 2016-08-31 | 2017-02-22 | 扬州大学 | 一种禽白血病病毒j亚群特异抗原多肽及其应用 |
-
2017
- 2017-03-24 CN CN201710183771.2A patent/CN106866798B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106442982A (zh) * | 2016-08-31 | 2017-02-22 | 扬州大学 | 一种禽白血病病毒j亚群特异抗原多肽及其应用 |
Non-Patent Citations (5)
Title |
---|
DELONG LI等: "Avian leukosis virus subgroup A and B infection in wild birds of Northeast China", 《VETERINARY MICROBIOLOGY》 * |
MINBO HOU等: "Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J", 《VACCINE》 * |
WEI PAN等: "Genetic diversity and phylogenetic analysis of glycoprotein GP85 of ALV-J isolates from Mainland China between 1999 and 2010: Coexistence of two extremely different subgroups in layers", 《VETERINARY MICROBIOLOGY》 * |
莫虹斐等: "J亚群禽白血病病毒gp85单抗1E3株抗原识别表位的初步分析", 《中国兽医杂志》 * |
郭文龙等: "AA肉种鸡内源性类ALV-J gp85基因及其抗原表位的分析", 《中国兽医学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107353324A (zh) * | 2017-07-05 | 2017-11-17 | 河南牧业经济学院 | 与禽白血病病毒p27蛋白相结合的多肽及其应用 |
CN107353324B (zh) * | 2017-07-05 | 2020-05-15 | 河南牧业经济学院 | 与禽白血病病毒p27蛋白相结合的多肽及其应用 |
CN114349829A (zh) * | 2022-01-14 | 2022-04-15 | 华南农业大学 | Alv-j mhc-b2限制性表位肽的鉴定及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN106866798B (zh) | 2020-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114057894B (zh) | 一种产生广谱交叉中和活性的重组新型冠状病毒rbd三聚体蛋白疫苗、其制备方法和应用 | |
CN107033250B (zh) | 牛冠状病毒重组多表位抗原及其应用 | |
JP2011514321A (ja) | H5亜型インフルエンザウイルスの普遍的な検出のための結合タンパク質およびエピトープブロッキングelisa | |
CN103756973B (zh) | 一种草鱼呼肠孤病毒的间接elisa检测试剂盒 | |
CN106442981B (zh) | 一种人博卡病毒1型抗体间接elisa诊断试剂盒 | |
CN109970852A (zh) | 分泌抗狂犬病毒m蛋白单克隆抗体的杂交瘤细胞株及应用 | |
CN104450627B (zh) | 鲤疱疹病毒3型囊膜蛋白orf132的单克隆抗体、杂交瘤细胞株及其应用 | |
CN109053883B (zh) | Ns1蛋白的结合蛋白 | |
CN106866797A (zh) | J亚群禽白血病病毒特异性抗原表位、融合蛋白、特异性抗体及其应用 | |
CN114874995A (zh) | 猪瘟病毒2型Erns蛋白的单克隆抗体杂交瘤细胞株及应用 | |
CN114702578B (zh) | 新型冠状病毒Omicron突变株特异性抗体及其应用 | |
CN109970851A (zh) | Ccv病毒m蛋白的单抗及其制备方法、免疫胶体金试纸条的制备方法 | |
KR20180038261A (ko) | H7n9 조류 인플루엔자 바이러스 검출을 위한 효소면역 측정키트 | |
Zhang et al. | Development and evaluation of a VP3-ELISA for the detection of goose and Muscovy duck parvovirus antibodies | |
CN106279378A (zh) | 水痘带状疱疹病毒gE抗原及其在检测抗水痘带状疱疹病毒抗体中的用途 | |
CN110272488A (zh) | 猫杯状病毒单克隆抗体及其应用 | |
CN111848750A (zh) | 一种快速富集和检测2019-nCoV的方法及试剂盒 | |
CN108414762A (zh) | 一种草鱼IgM单克隆抗体、其制备方法及其应用 | |
CN106866798A (zh) | J亚群禽白血病病毒特异性抗原表位、融合蛋白、特异性抗体及其应用 | |
CN110483625A (zh) | 一种牛支原体假想蛋白MbovP732及其应用 | |
CN116284349B (zh) | 一种猴痘抗体检测试剂盒 | |
CN109239341A (zh) | 一种牛溶血性曼氏杆菌抗体检测的间接elisa试剂盒及其应用 | |
CN109762825A (zh) | 一种酶联核酸适配体的鸡毒支原体抗体检测方法及其专用试剂盒 | |
CN106701687A (zh) | 一种杂交瘤细胞株及其产生的狂犬病毒磷蛋白单克隆抗体 | |
CN107664694B (zh) | 一种基于e2蛋白检测猪非典型瘟病毒抗体的elisa试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240703 Address after: Building 5, 4th Floor, Wen's Research Institute, East Huineng North Road, Xincheng Town, Xinxing County, Guangzhou City, Guangdong Province, China (Office Address) Patentee after: Guangdong Biaoyun Biotechnology Co.,Ltd. Country or region after: China Address before: China Agricultural University (East District), 17 Qinghua East Road, Haidian District, Beijing 100083 Patentee before: CHINA AGRICULTURAL University Country or region before: China |
|
TR01 | Transfer of patent right |